China reported using prostaglandin E1 PGE1100 ~ 200 mg intravenous infusion a daily treatments thromboangiitis obliterans. efficiency of 80.8%.
国内报道采用前列腺素e1PGE1100 ~ 200mg，静脉滴注，每日1次治疗血栓闭塞性脉管炎，有效率为80.8%。
One possible option in this setting is the off-label use of misoprostol, a synthetic prostaglandin E1 analogue licensed for prevention and treatment of gastrointestinal ulcers.
一种可能的选择是米索前列醇的标示外使用，这是一种合成的前列腺素E1类似物，被核准用于防止和治疗胃肠道溃疡。
Two groups were treated with diabetes missionary, regular exercise, dietary control and other conventional diabetes treatment, control group given prostaglandin E1 treatment factors;
两组患者均给予糖尿病宣教、适量运动、饮食控制等常规糖尿病治疗，对照组给予前列腺素E1治疗；
The hemodynamic effects of prostaglandin E1(PGE1)on pulmonary and systemic circulations were studied in 11 patients with rheumatic mitral disease complicated by pulmonary hypertension.
应用漂浮导管监测前列腺素E1（PGE1）对11例以二尖瓣狭窄为主的风湿性心脏病合并肺动脉高压患者的体循环和肺循环的血液动力学作用。
Objective The purpose of this study was to evaluate the effect of prostaglandin E1 (PGE1) on blocking the development of acute respiratory distress syndrome (ARDS) induced by acid aspiration.
目的研究静脉注射前列腺素E1（PGE1）能否阻止酸吸入性急性呼吸窘迫综合征（ARDS）的发生。
Objective The purpose of this study was to evaluate the effect of prostaglandin E1 (PGE1) on blocking the development of acute respiratory distress syndrome (ARDS) induced by acid aspiration.
目的研究静脉注射前列腺素E1（PGE1）能否阻止酸吸入性急性呼吸窘迫综合征（ARDS）的发生。
应用推荐